Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.3 DKK | +0.71% | -0.70% | +3.10% |
Apr. 23 | Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024 | |
Apr. 23 | Embla Medical hf. Provides Earnings Guidance for the Year 2024 | CI |
Sales 2024 * | 869M 5.98B | Sales 2025 * | 945M 6.5B | Capitalization | 1.76B 12.08B |
---|---|---|---|---|---|
Net income 2024 * | 72M 495M | Net income 2025 * | 86M 591M | EV / Sales 2024 * | 2.5 x |
Net Debt 2024 * | 412M 2.83B | Net Debt 2025 * | 383M 2.63B | EV / Sales 2025 * | 2.26 x |
P/E ratio 2024 * |
23.2
x | P/E ratio 2025 * |
19.4
x | Employees | 4,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 48.4% |
Latest transcript on Embla Medical hf.
1 day | +0.71% | ||
1 week | -0.70% | ||
1 month | -5.35% | ||
3 months | -10.73% | ||
6 months | -1.05% | ||
Current year | +3.10% |
Managers | Title | Age | Since |
---|---|---|---|
Sveinn Sölvason
CEO | Chief Executive Officer | 46 | 08-12-31 |
Director of Finance/CFO | 58 | 22-08-31 | |
Lukas Märklin
COO | Chief Operating Officer | - | 23-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 73 | 13-02-28 | |
Niels Jacobsen
CHM | Chairman | 66 | 04-12-31 |
Svafa Grönfeldt
BRD | Director/Board Member | 59 | 08-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 28.3 | +0.71% | 8,635 |
24-05-30 | 28.1 | +1.08% | 252,997 |
24-05-29 | 27.8 | -1.77% | 40,064 |
24-05-28 | 28.3 | +1.07% | 34,423 |
24-05-27 | 28 | -1.75% | 34,996 |
Delayed Quote Nasdaq Copenhagen, May 31, 2024 at 10:54 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.10% | 1.76B | |
-13.72% | 20.65B | |
+8.00% | 14.03B | |
+11.15% | 10.41B | |
-20.38% | 1.99B | |
+8.31% | 1.33B | |
+6.05% | 552M | |
-.--% | 421M | |
+69.47% | 196M | |
+11.28% | 88.9M |
- Stock Market
- Equities
- EMBLA Stock